Welcome to the first issue of the Latham & Watkins Drug Pricing Digest. Here, Latham’s government price reporting team provides a digest of recent developments, as reported in the trade press or published directly by government bodies, which we intend to distribute at the start of every second week. In this digest, we cover general developments, followed by sections focusing on the Medicaid Drug Rebate Program, the 340B Drug Pricing Program, Medicare Part B, and state law developments.
Please see full publication below for more information.
